Stocks Sanofi SA


  • Midday movers: Regeneron, Abbott, Sprint & more Wednesday, 16 Oct 2013 | 12:05 PM ET

    Take a look at some of Wednesday's midday movers:

  • After-hours buzz: BBRY, LPX & more Wednesday, 4 Sep 2013 | 5:12 PM ET

    Check out which companies are making headlines after the bell Wednesday:

  • Are drug companies giving up on heart research? Tuesday, 3 Sep 2013 | 12:50 PM ET

    As resources move to other areas, cardiologists fear the battle against heart disease could stall after advances marked by critical drugs to lower cholesterol and blood pressure.

  • Early movers: BIG, CRM, GE, KKD & more Friday, 30 Aug 2013 | 7:55 AM ET

    Some of the names on the move ahead of the open.

  • European shares closed slightly lower on Monday with fears of a government collapse in Italy dragging down the FTSE MIB, and with U.K. markets closed for a holiday.

  • China's benchmark index shot up to a seven-week high on Monday, boosting Asian stocks across the board on optimism that the world's second-largest economy may be stabilizing, but Japan bucked the trend after weak growth data.

  • China investigates Sanofi for alleged bribery Saturday, 10 Aug 2013 | 6:55 AM ET

    China has started investigating French drugmaker Sanofi for allegedly bribing more than 500 Chinese doctors with about 1.7 million yuan ($277,600) of payments to raise sales, China's Xinhua state news agency said on Saturday.

  • China drug sector probe widens as Novo site visited Thursday, 8 Aug 2013 | 6:07 AM ET

    Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk, the latest evidence of a widening investigation into Western drugmakers.

  • Royalty Pharma raised its hostile bid for Irish drug firm Elan to a potential $8 billion on Friday, coming back for the third time after just 7.5 percent of shareholders accepted the last offer.

  • Stocks to Shrug Off Blood-Pressure Drug Dispute Friday, 31 May 2013 | 4:29 PM ET

    A dispute within the FDA on whether to put new lung-cancer warnings on ARBs taken by millions of people is unlikely to have any significant effect on the manufacturers stocks.

  • Drug Spending Drops for the First Time in 55 Years Thursday, 9 May 2013 | 8:31 AM ET

    Patent expirations on big-name drugs has resulted in modestly less spending on medicines in the U.S. for the first time in at least 55 years, a report showed Thursday.

  • Fear on the Floor Ahead of Jobs Report Thursday, 2 May 2013 | 9:54 AM ET

    There's a lot of fear about Friday's jobs report. Bears are already saying this could be the report that finally forces the markets to take a breather.

  • Futures Gain After Jobless Claims, ECB Rate Cut Thursday, 2 May 2013 | 9:17 AM ET

    U.S. stock index futures climbed Thursday as Wall Street cheered a better-than-expected jobless claims report and after the European Central Bank cut its key interest rate.

  • Fed May Provide a Safety Net for the Market Friday, 26 Apr 2013 | 8:08 PM ET
    A trader at the Chicago Board Options Exchange (CBOE).

    The Fed is expected to repeat its dovish message in the coming week, which could provide a safety net for the market amid a big wave of earnings and the April jobs report.

  • Bird Flu Returns, but China's Better Prepared: CEO Thursday, 11 Apr 2013 | 2:11 PM ET
    Authorities in China confirmed infections caused by the H7N9 flu strain found in chicken and duck samples in eastern China.

    China is handling an outbreak of bird flu much better than in the past, Sanofi CEO Chris Viehbacher told CNBC on Thursday.

  • Sanofi CEO on Bird Flu Fears Thursday, 11 Apr 2013 | 1:25 PM ET
    Sanofi CEO on Bird Flu Fears

    Sanofi CEO Chris Viehbacher shares his opinion on how China has handled recent bird flu concerns and what impact President Obama's budget might have on pharmaceuticals.

  • China Rolls Up Sleeves in Fight Against Bird Flu Friday, 5 Apr 2013 | 12:32 AM ET
    bird flu-1200437469_v2.jpg

    China said it was mobilizing resources nationwide to combat a new strain of bird flu that has killed six people, as Japan, Hong Kong and the United States stepped up vigilance.

  • Pro's Best Buys in Health Care Tuesday, 26 Mar 2013 | 1:21 PM ET
    Best Buys in Health Care

    A few health care stocks still hold potential, Orbimed Advisors Managing Partner Sam Isaly says.

  • Weak Euro can be Good for Exporters Monday, 25 Mar 2013 | 11:05 PM ET
    Weak Euro can be Good for Exporters

    Simon Grose-Hodge, Head of Investment Advisory, Singapore at LGT Bank talks Cyprus and tells CNBC's Cash which stocks will benefit from the weak euro.

  • 4 Biotech Stock Stars Losing Their Luster Thursday, 21 Feb 2013 | 12:19 PM ET

    These four biotech stocks could take a big hit when investors start to focus on lower-valued stocks in other industries. reports.